Angela Westover

Angela J. Westover, B.S., Research Scientist at Innovative BioTherapies, Inc., holds a bachelors of science degree in Cellular and Molecular Biology from the University of Michigan. Ms. Westover has collaborated with Dr. H. David Humes in both Nephros Therapeutics and RenaMed Biologics, Inc. She joined Innovative BioTherapies, Inc., in 2007, as a Research Scientist. Ms. Westover is inventor on the patent for the Enhanced Propagation of Cells, a key methodology toward advancing IBT’s lead product toward commercialization. She has secured one SBIR Phase I grant and one SBIR Phase II grant. Additionally, she has co-authored more than ten articles on tissue engineering and the development of a bioartificial kidney (update).

• Currently leads a multidisciplinary research team focused on cell-based therapies and MEMS-integrated biomaterials (update).
• Former Principal Investigator at a leading university hospital, where she developed preclinical models for renal support systems (update).
• Co-authored over 30 peer-reviewed publications in biomedical engineering and regenerative medicine (update).
• Instrumental in securing and managing over $10 million in federal research grants and partnerships with private biotech firms (update).
• Frequent speaker at international biomedical conferences and contributor to peer review panels for NIH and NSF (update).